Contact Us


Margaret McNeely, PhD


Rehabilitation Medicine | Medicine & Dentistry

Physical Therapy | Oncology

About Me


Margaret (Margie) McNeely is an Associate Professor in the Department of Physical Therapy at the University of Alberta in Edmonton, Canada. She currently holds a joint appointment in the Department of Oncology (Division of Radiation Oncology) and performs clinical research in the Rehabilitation Medicine Department at the Cross Cancer Institute. 


Professional Interests

  • Impairment-based cancer rehabilitation and therapeutic exercise
  • Shoulder function in survivors of cancer
  • Cancer-related peripheral nerve injury 
  • Cancer-related symptoms of pain, fatigue and lymphedema

Current Research Projects (click on study title for more information)

1.  Alberta Moving Beyond Breast Cancer (AMBER)

CIHR Team in Physical Activity and Breast Cancer Survivorship Cohort Study. Leads: Dr. Kerry Courneya and Dr. Christine Friedenreich. Co-principal applicant: Dr. McNeely. Centres: Edmonton: Cross Cancer Institute and University of Alberta; Calgary:  Holy Cross Centre and University of Calgary. 

Funding:  Canadian Institutes of Health Research

2.  Night-time Compression for Breast Cancer Related Lymphedema (LYNC):  A Multi-centre Randomized Fast-track Trial 

A multi-centre randomized trial examining the efficacy of night-time compression as a self-management intervention for breast cancer related lymphedema. Principal investigator: Dr. McNeely.  Centres:  Edmonton: Cross Cancer Institute; Calgary: Tom Baker Cancer Centre (Holy Cross site); Vancouver: University of British Columbia. 

Funding: Investigator Initiated Trials: Alberta Cancer Foundation and Canadian Institutes of Health Research

3.  Multidisciplinary Team Intervention in Cardio-Oncology (TITAN) 

A randomized controlled trial examining the effect of a multi-disciplinary assessment and early intervention strategy to prevent short and long-term side effects resulting from cancer and cancer treatments in patients who are undergoing treatment for breast cancer and lymphoma.  Principal Investigator:  Dr. Ian Paterson. Co-investigator: Dr. McNeely. Centres: Edmonton: University of Alberta and Cross Cancer Institute. 

Funding: Mazankowski Heart Institute

4.  Ultrasound Therapy and Therapeutic Exercise for Chemotherapy Induced Peripheral Neuropathy (ULTRA)

The primary purpose of the trial is to determine the preliminary efficacy of therapeutic ultrasound in the treatment of pain and sensory disturbance related to chemotherapy induced peripheral neuropathy. Co-Principal Investigators:  Ms. Janice Yurick and Dr. Margie McNeely. Sites: Cross Cancer Institute and Cancer Rehab Clinic, University of Alberta. 

Funding: University of Alberta Department of Physical Therapy and the Alberta Physiotherapy College and Association

5. Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors (TARGET)

A randomized controlled trial examining 12-week, 24-week and one year outcomes from a combined therapeutic and physical exercise program that aims to bridge head-and-neck cancer survivors from acute care rehabilitation services to community-based exercise programming. Principal Investigator: Dr. McNeely.  Site: Cancer Rehab Clinic, University of Alberta.

6.  Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study (ACE)

The primary purpose of this proposed 5-year hybrid effectiveness and implementation study is to evaluate the relative benefit from, and implementation of an Alberta wide clinic-to-community-based cancer exercise model of care - the Alberta Cancer Exercise (ACE) Program. Lead: Dr. McNeely.  Co-leads:  Dr. Nicole Culos-Reed and Ms. Melissa Shea-Budgell. Sites: Across Alberta.  Local Edmonton sites:  Cancer Rehab Clinic (University of Alberta), Don Wheaton YMCA, Castledowns YMCA and Wellspring Edmonton. 

Funding: Alberta Innovates Cancer Prevention Research Opportunity 

7. ACE Prostate Cancer

The exercise program of the TrueNTH Lifestyle Management Program is offered in the Cancer Rehab Clinic at the University of Alberta through the ACE study.  Principal Investigator for ACE:  Dr. McNeely; Principal Investigator for TrueNTH:  Dr. Nicole Culos-Reed, University of Calgary.  Site: Cancer Rehab Clinic.